# The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

> **NCT03693950** · PHASE1 · COMPLETED · sponsor: **Biocad** · enrollment: 57 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** BCD-066
- **BIOLOGICAL:** Aranesp

## Key facts

- **NCT ID:** NCT03693950
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-28
- **Primary completion:** 2017-07-03
- **Final completion:** 2017-07-03
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03693950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03693950, "The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03693950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*